(Q33389149)

English

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

scientific article

Statements

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome (English)
Alexandra Holowiecka
Joaquín Díaz-Mediavilla
PETHEMA and HOVON Groups

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit